In 2025, Life Sciences and Health Care (LS&HC) companies face rapidly evolving regulatory paradigms that create transactional risks and require daily monitoring. After more than 70 national elections in 2024, the dust hasn’t...more
8/25/2025
/ Artificial Intelligence ,
Clinical Trials ,
Cybersecurity ,
Digital Health ,
Environmental Social & Governance (ESG) ,
Genetic Materials ,
Government Agencies ,
Healthcare ,
Healthcare Reform ,
Innovative Technology ,
Life Sciences ,
Pharmaceutical Industry ,
Public Health ,
Regulatory Oversight ,
Regulatory Reform ,
Regulatory Requirements ,
Risk Management ,
Supply Chain ,
Trump Administration
On May 12, 2025, the U.S. Department of Justice (DOJ) announced revisions to key corporate criminal enforcement policies. The revisions’ stated aim is to provide more clarity and certainty of outcome to companies that...more
At a legal industry event on 9 April 2025, Marcelo Pontes Vianna, the head of the secretariat for private integrity of Brazil's Office of the Comptroller General (CGU), the national antibribery agency, highlighted Brazil's...more
In an era where digital transactions are increasingly vulnerable to sophisticated fraud, regulators around the world are stepping up to enhance consumer protection and cybersecurity. Singapore's Shared Responsibility...more
1/14/2025
/ Banking Sector ,
Banks ,
Compliance ,
Cybersecurity ,
EU ,
Financial Institutions ,
Fraud ,
Regulatory Agenda ,
Regulatory Reform ,
Regulatory Requirements ,
Singapore ,
UK